News & Statements
T1International Statement on HR 6833 and the Affordable Insulin Now Act Vote
31 Mar 2022, 8 p.m. in #insulin4all USA, News & Statements by T1International
On Thursday, March 31st, the US House of Representatives voted to pass a $35 insulin copay cap. The bill now heads to the Senate. While a $35 copay cap on insulin would impact many people, T1International is calling on the Senate to pass a true price cap on insulin for everyone, especially those without insurance. Read more
The Next 100 Years of Insulin
24 Mar 2022, 11:11 p.m. in #insulin4all USA, Global Stories, News & Statements by Ian Devaney
For some, the first 100 years of insulin has been a great, life-affirming success. For others, it has been a failure, where leaders and organizations in power have chosen profits over the lives and welfare of human beings. So how will we shape the next 100 years? Read more
6 Strategies for Ethical Patient Engagement
18 Feb 2022, 10:33 a.m. in #insulin4all USA, News & Statements by T1International
More and more organisations today, from NGOs to global health alliances, are expressing a need for patient engagement and claiming to be patient-informed. As a patient-led organisation, we have noted that patient engagement is often well-intentioned but misguided. While patients might be acknowledged as experts on an event flyer or web page, that expert status does not necessarily mean they are compensated equitably or that their perspectives are valued and/or integrated comparably to other accepted experts, such as physicians or academic researchers. Read more
T1International’s 2021 Top Ten
20 Dec 2021, 5:26 p.m. in News & Statements by T1International
Another year of challenges and outrage, another year of incredible advocacy by our T1International Community! For 2021, we’ve decided to create a Top 10 list of some of our biggest collective achievements. Read more
Greed v. Alec’s Law: Oral Argument at the Eighth Circuit
15 Dec 2021, 2:12 p.m. in #insulin4all USA, News & Statements by Jesus Morales Sanchez
T1International is proud to join T1International’s Minnesota #insulin4all Chapter and patient advocates at the oral argument before the United States Court of Appeals for the Eighth Circuit (Eighth Circuit) in support of upholding Minnesota’s Alec Smith Insulin Affordability Act (Alec’s Law) on December 15, 2021. Read more
T1International Publishes Survey on Type 1 Diabetes, COVID, and Insulin Rationing
18 Oct 2021, 3:15 p.m. in #insulin4all USA, News & Statements by T1International
In September 2021, T1International’s latest out-of-pocket cost survey was published in the Journal of Diabetes Research and Clinical Practice. Conducted every two years, this study is the most comprehensive patient-led out-of-pocket cost survey for people living with type 1 diabetes. Read more
T1International Advocates Win: WHO Adds Long-Acting Insulin Analogues to EML
1 Oct 2021, 2:45 p.m. in News & Statements by T1International
T1International’s global community of people living with and affected by diabetes and their allies celebrates a monumental advocacy win as the World Health Organization announced the addition of long-acting insulin analogues to the Model List of Essential medicines (EML). Read more
T1International Hosts 3rd Annual #insulin4all Workshop
13 Sep 2021, 6:38 p.m. in #insulin4all USA, News & Statements by T1International
Join us for T1International’s annual #insulin4all Workshop: Advocate, Don’t Celebrate. This event is an opportunity for advocates from around the world to learn from each other, build community, and take action in the fight for #insulin4all. Read more
T1International Comment on Application to Add Long-acting Insulin Analogues to WHO EML
17 Jun 2021, 9:03 a.m. in News & Statements by T1International
The WHO justifying inaction by saying it will not be adequate fails to address the issue of manufacturer monopolies and price-gouging. To see a world health leader taking this stance is extremely disheartening. Not to mention, civil society groups, including T1International, have coordinated actions to address the root causes of the issue. If the application is rejected for a third time, the diabetes community will continue to feel that the voices of people with diabetes do not matter and that the WHO is not listening to those who live this reality every day. Read more
T1International Statement Endorsing H.R.3
2 Jun 2021, 9:59 a.m. in News & Statements
For years, T1International and our advocates have been calling on both state and federal legislators to take action to address exorbitant drug prices. American lives depend on real action. That’s why T1International USA endorses the Elijah E. Cummings Lower Drug Costs Now Act (H.R.3). Read more